Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development (including related party expenses of $0 and $747 for the three months ended June 30, 2022 and 2021, respectively, and $0 and $2,359 for the six months ended June 30, 2022 and 2021, respectively	$ 38,469	$ 17,651	$ 70,147	$ 34,909
General and administrative	9,417	6,079	16,960	11,964
Total operating expenses	47,886	23,730	87,107	46,873
Loss from operations	(47,886)	(23,730)	(87,107)	(46,873)
Other income (expense), net:
Interest Expense	(2)	(7)	(2)	(7)
Interest income	399	93	533	155
Grant income	690	378	850	378
Realized gain on marketable securities	0	1	0	1
Foreign currency transaction gains	(1,733)	(414)	(1,792)	1,447
Total other income (expense), net	(646)	51	(411)	1,974
Net loss	$ (48,532)	$ (23,679)	$ (87,518)	$ (44,899)
Net loss per share, basic	$ (0.80)	$ (0.46)	$ (1.48)	$ (0.87)
Net loss per share, diluted	$ (0.80)	$ (0.46)	$ (1.48)	$ (0.87)
Weighted-average shares outstanding, basic	60,818,778	51,508,340	59,192,182	51,342,585
Weighted-average shares outstanding, diluted	60,818,778	51,508,340	59,192,182	51,342,585